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Abstract 
Novel diamine-dioxime ligand, 4,7-diaza-3,8-diethyldecane-2,9-dione bis oxime 
(LH2), derivative of hexamethyl-propylene amine oxime (HMPAO), was 
synthesized in order to develop new brain perfusion imaging agent, based on 
99mTc(V) complexes. The 99mTc(V)-d,l-HMPAO complex is well-known 
radiopharmaceutical for brain imaging. The structures of the synthesized 
compound were characterized by UV-Vis, IR, 1H NMR and 13C NMR. The 
procedure for radiolabeling of diamine-dioxime with 99mTc was developed and 
radiolabeling yield of the 99mTc-complex was followed by paper and thin-layer 
chromatography. The maximum radiolabeling yield was obtained when the 
reactions were carried out at pH~9 within 10 min at room temperature (RT). 
Biodistribution studies on rats has shown significant uptake of 99mTc-complex 
(2.1% ID), 2 min after injection.   
 
Introduction 
The clinical usefulness of 99mTc-labeled complexes depends on their ability to 
rapidly cross cell membranes, high stability and rapid clearance from vital organs 
and tissues [1]. Among radiopharmaceuticals for imaging cerebral blood flow 
(CBF) by single-photon emission computed tomography (SPECT) in nuclear 
medicine, 99mTc-d,l-HMPAO (hexamethyl-propylene amine oxime) and 99mTc-l,l-
ECD (ethyl cysteinate dimer), combine the best overall features of high brain 
uptake, fixed regional distribution within the brain and their distribution in the 
brain is proportional to CBF in a wide range [2]. Both the ligands form neutral and 
lipophilic complexes with 99mTc possessing an oxotechnetium core. The HMPAO 
belongs to the class of diamine-dioxime compounds, which are good chelating 
agents due to the presence four nitrogen atoms that coordinate with 99mTc(V) in 
aqueous media. The goal of this work was to examine the use of a new ligand, 
derivative of HMPAO, as a potential candidate for the brain-perfusion imaging in 
SPECT. Although the ligand shows stereoisomerism, the presented work is based 
on research of isomeric mixtures of the meso- and d,l- diastereoisomers without the 






99mTc (T1/2=6 h, Eγ=140 keV) was eluted from a 99Mo-99mTc generator (The Vinča 
Institute of Nuclear Sciences, Belgrade, Serbia). All reagents obtained from 
commercial sources were of analytical grade and used without further purification. 
IR spectra were recorded on a Bomem MB 100 IR spectrophotometer using prepared 
KBr pellets. The 1H and 13C NMR spectral measurements were performed on a 
Varian Gemini 2000 (200 MHz) at RT with deuterated DMSO (d6-DMSO) as 
solvents. The melting points were determined by Mel-Temp melting point apparatus 
(Laboratory Devices Inc., USA). Radioactivity measurements were done in a NaI(TI) 
well-type gamma counter (LKB Wallac Compu Gamma Counter, Finland). 
Spectrophotometric measurements were carried out using an Uvicon 810/820 
spectrophotometer (Kontron Instruments, Austria) with 10 mm quartz cells. 
Preparation of ligand. 4,7-diaza-3,8-diethyldecane-2,9-dione bis oxime (LH2) was 
prepared using the method described in the literature [3]. Yield: 80%, mp: 133-134 
°C. λ max= 205 nm. Selected IR data (KBr, pallets, cm-1): νOH 3264, ν(OH, NH) 3212. 
1H NMR (200 MHz, DMSO-d6, δ ppm): 0.76 (CH3(C5), 3H, t, J=7.5 Hz), 1.35-
1.50 (CH2(C4), 2H, m), 1.62 (CH3(C1), 3H, s), 2.34 (CH2(C6), 2H, s), 2.90 
(CH(C3), 1H, t, J=7.3 Hz), 10.32 (-OH, 1H, s). 13C NMR (200 MHz, DMSO-d6, δ 
ppm): 10.89 C(1), 157.56 C(2), 63.12 C(3), 25.83 C(4), 8.37 C(5), 46.50 C(6).  
 
Results and Discussion 
Radiolabeling procedure. Radiolabeling conditions were optimized to give the 
maximum yield of 99mTc-complex. Complexation studies of ligand with 99mTc(V) 
were carried out using SnCl2 as a reducing agent. Dissolution of desire amount of 
LH2 in oxygen-free double-distilled H2O was achieved by acidification with HClconc 
to pH 1.5-2. The solution was bubbled with N2 gas and cooled in an ice bath. Then, 
appropriate volume of SnCl2 stock solution (5 mg of anhydrous SnCl2 in 0.05 ml of 
HClconc diluted up to 10 mL of H2O) was added and the pH adjusted to 9. After the 
addition of sodium pertechnetate (99mTcO4¯, 18.5-37 MBq/mL), the solution was 
gently shaken and allowed to stand 10 min at RT. The total reaction volume in vial 
was maintained at 4 mL. Sn(II):LH2 mole ratio was 1:55. 
 
               
            Figure 1. Structure of LH2 and proposed structure of  99mTc-complex. 
 
According to the literature data for similar diamino-dioxime ligands and 
their 99mTc(V)-labeled complexes [4], proposed structures of LH2 and 99mTc-
complex are shown in Fig.1. Numbering of C-atoms in Fig.1 was used for 1H NMR 
and 13C NMR spectra interpretation.  
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Radiolabeling yield. The labeling yield as well as the stability of the 99mTc-complex 
were determined using a combination of two chromatographic systems: paper 
chromatography on Whatman No.1 with acetonitrile:water (1:1) as the mobile 
phase and TLC on silica gel 60 strips with saline as the mobile phase. Stability of 
the 99mTc-complex was determined by investigation of radiochemical purity of the 
complex at different time intervals after labeling (Fig.2A). The content of free 
99mTcO4¯ and 99mTc-reduced-hydrolyzed in the form of 99mTcO2 were considered as 
radiochemical impurities.  
Biodistribution of 99mTc-complex. Healthy male 8-weeks old Wistar rats, 200-250 g 
body weight (n=3 per each time point) were intravenously (i.v.) injected through the 
tail vein with 0.1 mL of 99mTc-complex (approx. 0.5–1.0 MBq per animal). The 
animals were sacrificed via spinal cord dislocation at 2, 5, 15, 30 and 60 min after 
injection and the radioactivity in brain was measured. 99mTc-complex exhibits good 
uptake in the brain (2.10% of injected dose (%ID)) at 2 min after injection (Fig.2B.) 
 
 
                        
Figure 2. Radiochemical purity(A); Brain uptake(B) of the 99mTc-complex. 
 
Conclusion 
A new diamine-dioxime ligand, 4,7-diaza-3,8-diethyldecane-2,9-dione bis oxime 
(LH2) were synthesized in high yields, characterized by UV-Vis, IR, 1H, and 13C 
NMR and successfully labeled with 99mTc(V). From the obtained results, it can be 
concluded that 99mTc(V) complex could be made easy with a ligand such as LH2. 
This complex showed good stability, higher than 94% up to 4h during storage at 
RT. The present study suggests that complex exhibited favorable properties as 
promising candidates for cerebral perfusion imaging. 
 
References 
[1]  M. Mallia, S. Subramanian, et al, Bioorg. Med.Chem. 2006, 14, 7666-7670. 
[2]   F. Shishido, K. Uemura, et al, J. Cereb. Blood. Flow Metab. 1994, 14, 66-75. 
[3]   S. Banerjee, G. Samuel, et al, Nucl. Med. Biol., 1999, 26, 327-338. 
[4]   L. Canning, et al, United States Patent, Patent number 4.789.736, 1988, 
CIP Volime II 
 
CIP - Каталогизација у публикацији 






MEĐUNARODNA konferencija iz fundamentalne i  
primenjene fizičke hemije (11 ; 2012 ;        
Beograd) 
   Physical Chemistry 2012 : proceedings.     
#Vol. #2 / 11th International Conference on   
Fundamental and Applied Aspects of Physical   
Chemistry, September 24-28, 2012, Belgrade ;  
[editors S.[Slobodan] Anić and Ž.[Željko]     
Čupić ; organized by Society of Physical      
Chemists of Serbia ... et al.]. - Belgrade :  
Society of Physical Chemists of Serbia, 2012  
(Belgrade : Jovan). - VI str., 499-782 str. : 
ilustr. ; 24 cm 
 
"The Conference is dedicated to Professor     
Ivan Draganić" --> nasl. str. - Tiraž 200. - 
Bibliografija uz svaki rad. - Registar. 
 
ISBN 978-86-82475-28-6 
1. Društvo fizikohemičara Srbije (Beograd) 
a) Физичка хемија - Зборници b)             
Електрохемијско инжењерство - Зборници c)  
Наука о материјалима - Зборници 
COBISS.SR-ID 193433356 
